This Week at Team Talk…Stimulants & ADHD
Attention-Deficit Hyperactivity Disorder (ADHD) is a chronic, neurobehavioral disorder with symptoms of inattention and/or hyperactivity and impulsivity. These symptoms, when untreated, can interfere with many aspects of life, including work and social functioning.
This week at Union Square Practice, Matt Buttigieg provided an overview of the etiology of ADHD and the benefits of stimulants in treatment.
Aspects of ADHD that were discussed, include:
- Specific subtypes – Inattentive and Hyperactive
- Diagnostic and Presenting features
- Comorbid disorders
Also discussed were the various types of stimulants that have been shown to be effective in treating many of the symptoms of ADHD. Some of the information discussed include:
- Different categories of stimulants
- Neurotransmitter mechanisms
- Specific benefits
- Potential side effects
- Potential for abuse
Matt emphasizes to both prescribers and clients that it is imperative to monitor physical changes, as well as other adverse effects, while using stimulants.
Team Talk at Union Square Practice takes place on a weekly basis. It is an open forum for both the USP team and guest speakers to discuss topics including psychopharmacology, therapeutic developments, and other relevant material in the field.
Comments are closed.